Regardless of the exact method, it is crucial to evaluate the potential to modify clinical features in FS by post-natal restoration of FoxG1 function to determine if strategies such as gene therapy are worthwhile to pursue, or if alternative strategies should be developed to treat this severe neurodevelopmental disorder. The gene discussed is FOXG1; the disease is neurodevelopmental disorder.